Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells

[1]  W. Birchmeier,et al.  Reconstitution of Mammary Gland Development In Vitro: Requirement of c-met and c-erbB2 Signaling for Branching and Alveolar Morphogenesis , 1998, The Journal of cell biology.

[2]  W. Birchmeier,et al.  Role of morphogenetic factors in metastasis of mammary carcinoma cells , 1998, Oncogene.

[3]  A. Welcher,et al.  Effect of neu differentiation factor isoforms on neonatal oligodendrocyte function , 1997, Journal of neuroscience research.

[4]  J. Rhim,et al.  ErbB kinases and NDF signaling in human prostate cancer cells , 1997, Oncogene.

[5]  A. Ullrich,et al.  Distinct characteristics of heregulin signals mediated by HER3 or HER4 , 1997, Journal of cellular physiology.

[6]  M. Sliwkowski,et al.  γ-Heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175 , 1997, Oncogene.

[7]  P. Fedi,et al.  Epidermal growth factor and betacellulin mediate signal transduction through co‐expressed ErbB2 and ErbB3 receptors , 1997, The EMBO journal.

[8]  M. Sliwkowski,et al.  Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  F. Maurer,et al.  Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells. , 1997, Cancer research.

[10]  D. M. Kopp,et al.  Glial Growth Factor Rescues Schwann Cells of Mechanoreceptors from Denervation-Induced Apoptosis , 1997, The Journal of Neuroscience.

[11]  Walter Gilbert,et al.  Ligands for ErbB-family receptors encoded by a neuregulin-like gene , 1997, Nature.

[12]  J. Weber,et al.  Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases , 1997, Nature.

[13]  W. Gullick,et al.  A potential autocrine loop between heregulin-alpha and erbB-3 receptor in human prostatic adenocarcinoma. , 1997, British journal of urology.

[14]  K. Livak,et al.  Real time quantitative PCR. , 1996, Genome research.

[15]  C. Heid,et al.  A novel method for real time quantitative RT-PCR. , 1996, Genome research.

[16]  Y. Yarden,et al.  Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. , 1996, The EMBO journal.

[17]  Y. Yarden,et al.  ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. , 1996, The EMBO journal.

[18]  Y. Yarden,et al.  Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2 , 1995, Molecular and cellular biology.

[19]  Carmen Birchmeier,et al.  Multiple essential functions of neuregulin in development , 1995, Nature.

[20]  Kuo-Fen Lee,et al.  Requirement for neuregulin receptor erbB2 in neural and cardiac development , 1995, Nature.

[21]  T. van Raaij,et al.  The cellular response to neuregulins is governed by complex interactions of the erbB receptor family , 1995, Molecular and cellular biology.

[22]  Y. Yarden,et al.  Neu Differentiation Factor Inhibits EGF Binding , 1995, The Journal of Biological Chemistry.

[23]  L. Cantley,et al.  Heregulin Stimulates Mitogenesis and Phosphatidylinositol 3-Kinase in Mouse Fibroblasts Transfected with erbB2/neu and erbB3(*) , 1995, The Journal of Biological Chemistry.

[24]  Y. Yarden,et al.  Studies on the Structure and Function of Glycosylated and Nonglycosylated neu Differentiation Factors , 1995, The Journal of Biological Chemistry.

[25]  M. Sliwkowski,et al.  The influence of heregulins on human Schwann cell proliferation , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  W. Gullick,et al.  NDF/heregulin stimulates the phosphorylation of Her3/erbB3 , 1994, FEBS letters.

[27]  W. Dougall,et al.  Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  G. Plowman,et al.  Heregulin induces tyrosine phosphorylation of HER4/p180erbB4 , 1993, Nature.

[29]  M. Waterfield,et al.  Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system , 1993, Nature.

[30]  William Arbuthnot Sir Lane,et al.  ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family , 1993, Cell.

[31]  G. Fischbach,et al.  ARIA, a protein that stimulates acetylcholine receptor synthesis, also induces tyrosine phosphorylation of a 185-kDa muscle transmembrane protein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Bissell,et al.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Goeddel,et al.  Identification of Heregulin, a Specific Activator of p185erbB2 , 1992, Science.

[34]  R. Koski,et al.  Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit , 1992, Cell.

[35]  Yosef Yarden,et al.  Isolation of the Neu HER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells , 1992, Cell.

[36]  R. Lupu,et al.  Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Aaronson,et al.  Growth factors and cancer. , 1991, Science.

[38]  K. Dobashi,et al.  Characterization of a neu/c-erbB-2 protein-specific activating factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Y. Yarden,et al.  Biochemical analysis of the ligand for the neu oncogenic receptor. , 1991, Biochemistry.

[40]  Michael Cross,et al.  Growth factors in development, transformation, and tumorigenesis , 1991, Cell.

[41]  C. Paraskeva,et al.  Colorectal carcinogenesis: sequential steps in the in vitro immortalization and transformation of human colonic epithelial cells (review). , 1990, Anticancer research.

[42]  A. Ullrich,et al.  Expression of the p185 encoded by her2 oncogene in normal and transformed human tissues , 1990, International journal of cancer.

[43]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[44]  A. Ullrich,et al.  Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Sporn,et al.  Peptide growth factors are multifunctional , 1988, Nature.

[46]  M. Kraus,et al.  Overexpression of the EGF receptor‐related proto‐oncogene erbB‐2 in human mammary tumor cell lines by different molecular mechanisms. , 1987, The EMBO journal.

[47]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[48]  P. Seeburg,et al.  Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. , 1985, Science.

[49]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[50]  D. Taverna,et al.  Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells. , 1995, Molecular endocrinology.

[51]  P. Yaswen,et al.  Growth, differentiation, and transformation of human mammary epithelial cells in culture. , 1994, Cancer treatment and research.

[52]  N. Lemoine,et al.  The type 1 (EGFR-related) family of growth factor receptors and their ligands. , 1992, Progress in growth factor research.

[53]  M. Lippman,et al.  Quantification of erbB-2/neu levels in tissue. , 1991, Methods in enzymology.

[54]  David I. Steinberg.  Burma In 1984: Unasked Questions, Unanswered Issues , 1985 .